(Q79291114)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17058223%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

title

Controversies in the management of pediatric liver disease: Hepatitis B, C and NAFLD: Summary of a single topic conference (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17058223%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

1 reference

Benjamin L Shneider

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17058223%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Regino González-Peralta

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17058223%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

Eve A Roberts

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17058223%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

language of work or name

English

0 references

publication date

1 November 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17058223%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17058223%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17058223%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17058223%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

page(s)

1344-1354

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17058223%20AND%20SRC:MED&resulttype=core&format=json

Chronic hepatitis B: a critical appraisal of current approaches to therapy

21 December 2019

cites work

1 reference

7 January 2021

Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma

1 reference

7 January 2021

Natural history of hepatitis B virus infection in children.

1 reference

7 January 2021

Precore stop codon mutant in chronic hepatitis B virus infection in children: its relation to hepatitis B e seroconversion and maternal hepatitis B surface antigen

1 reference

7 January 2021

Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination

1 reference

7 January 2021

Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan.

1 reference

7 January 2021

Childhood Cancer Among Alaska Natives

1 reference

7 January 2021

Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan.

1 reference

7 January 2021

Long-term follow-up of chronic hepatitis B virus infection in children of different ethnic origins

1 reference

7 January 2021

Natural history of hepatitis B in perinatally infected carriers

1 reference

7 January 2021

1 reference

7 January 2021

Hepatocellular carcinoma and liver tumors in South African children: a case for increased prevalence

1 reference

7 January 2021

Childhood hepatocellular carcinoma develops exclusively in hepatitis B surface antigen carriers in three decades in Taiwan. Report of 51 cases strongly associated with rapid development of liver cirrhosis

1 reference

7 January 2021

Primary hepatocellular carcinoma and hepatitis B infection during childhood

1 reference

7 January 2021

Management of hepatocellular carcinoma

1 reference

7 January 2021

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

1 reference

7 January 2021

Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial.

1 reference

7 January 2021

Clinical trial of lamivudine in children with chronic hepatitis B.

1 reference

7 January 2021

Combined lamivudine/interferon-alpha treatment in "immunotolerant" children perinatally infected with hepatitis B: a pilot study

1 reference

7 January 2021

Estimating future hepatitis C morbidity, mortality, and costs in the United States

1 reference

7 January 2021

The burden of hepatitis C virus infection in children: estimated direct medical costs over a 10-year period

1 reference

7 January 2021

Mother-to-infant transmission of hepatitis C virus

1 reference

7 January 2021

Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis

1 reference

7 January 2021

Chronic hepatitis C in children: the pathological and clinical spectrum.

1 reference

7 January 2021

Hepatitis C virus (HCV) genotypes in 373 Italian children with HCV infection: changing distribution and correlation with clinical features and outcome

1 reference

7 January 2021

Hepatitis C infection and hepatocellular carcinoma after treatment of childhood cancer

1 reference

7 January 2021

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

1 reference

7 January 2021

Immunology of hepatitis B virus and hepatitis C virus infection

1 reference

7 January 2021

Liver histology and alanine aminotransferase levels in children and adults with chronic hepatitis C infection

1 reference

7 January 2021

Treatment of acute and chronic hepatitis C.

1 reference

7 January 2021

An analysis of published trials of interferon monotherapy in children with chronic hepatitis C.

1 reference

7 January 2021

Interferon-alpha and ribavirin treatment of hepatitis C in children with malignancy in remission.

1 reference

7 January 2021

Interferon-alpha and ribavirin in treating children and young adults with chronic hepatitis C after malignancy

1 reference

7 January 2021

Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C.

1 reference

7 January 2021

Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics

1 reference

7 January 2021

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

7 January 2021

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

7 January 2021

Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C.

1 reference

7 January 2021

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin.

1 reference

7 January 2021

1 reference

7 January 2021

Non-alcoholic fatty liver disease (NAFLD) in children

1 reference

7 January 2021

Rapid recurrence of nonalcoholic fatty liver disease after transplantation in a child with hypopituitarism and hepatopulmonary syndrome

1 reference

7 January 2021

Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction

1 reference

7 January 2021

Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.

1 reference

7 January 2021

From fat to inflammation

1 reference

7 January 2021

Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?

1 reference

7 January 2021

Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease

1 reference

7 January 2021

Histopathology of pediatric nonalcoholic fatty liver disease.

1 reference

7 January 2021

Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents

1 reference

7 January 2021

Undetected hepatomegaly in obese children by primary care physicians: a pitfall in the diagnosis of pediatric nonalcoholic fatty liver disease

1 reference

7 January 2021

Underdiagnosis of pediatric obesity and underscreening for fatty liver disease and metabolic syndrome by pediatricians and pediatric subspecialists

1 reference

7 January 2021

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

7 January 2021

Establishing a standard definition for child overweight and obesity worldwide: international survey

1 reference

7 January 2021

Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children

1 reference

7 January 2021

A reduced-glycemic load diet in the treatment of adolescent obesity.

1 reference

7 January 2021

Safety of drug therapies used for weight loss and treatment of obesity

1 reference

7 January 2021

Bariatric surgery for severely overweight adolescents: concerns and recommendations

1 reference

7 January 2021

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21373

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17058223%20AND%20SRC:MED&resulttype=core&format=json

21 December 2019

1 reference